Close

LOGIN

Remember me
Not a member?
or
Connect using:
Why BS?

We encourage visitors to register on Business Standard. Registering on the site is absolutely Free and offers you the following benefits.

Free Daily E-newsletter

Breaking News Alerts in your Inbox

Post Comments and Share your Feedback

Your Personal Business Standard Page

Free Portfolio of Stocks, Equity and Commodities Derivatives

Access Premium Services

Receive Selective Offers from our Third Party Premium Advertisers

Get Invited to Business Standard Events

Close

FORGOT PASSWORD?

Not a member?
Companies » News

News Rss icon

I can stand behind every pill: Ranbaxy CEO

Drug maker Ranbaxy Laboratories, which recently pleaded guilty of making fraudulent statements to the US Food and Drugs Administration (US FDA) ...

Hefty price fails to deter bidders for Mumbai's Cadbury House

Prime property rates in South Mumbai at Rs 60,000 a sq ft remain high despite a slowing realty market

Google to build wireless networks across Africa

Google Inc intends to finance, build and help operate wireless networks from sub-Saharan Africa to Southeast Asia, hoping to connect a billion ...

Lower revenue, exceptional items drag Jet books in Q4

Jet Airways (India) Ltd's domestic operations contributed to a bulk of its Rs 743 crore consolidated loss for the fourth quarter, whereas its ...

Features Rss icon

For India Inc, office relationships are no longer just a private affair

Companies put in strict disclosure, job switch clauses in HR policies

Complete Coverage | Ranbaxy: in need of a booster dose

Read the latest news and views on Ranbaxy controversy as it unfolds

Not for the faint-hearted

What Force Motors' new Gurkha lacks in grace and elegance, it more than makes up with its rugged sinews and willingness to take on everything ...

The coolest way to use an air conditioner

A malfunctioning AC may have more to do with how you use it than how good its innards are

CompaniesRss icon

I can stand behind every pill: Ranbaxy CEO

Drug maker Ranbaxy Laboratories, which recently pleaded guilty of making fraudulent statements to the US Food and Drugs Administration (US FDA) ...

People will fly if price is right: Neil Mills

Interview with CEO, SpiceJet

Lower revenue, exceptional items drag Jet books in Q4

Jet Airways (India) Ltd's domestic operations contributed to a bulk of its Rs 743 crore consolidated loss for the fourth quarter, whereas its ...


HC clears way for Mallya's deal with Diageo

Mallya and Diageo in Nov 2012, had signed a multi-stage deal in which Diageo was supposed to get up to 53.4% stake in United Spirits

Vijay Mallya riles banks more with 'unilateral' step

Cancels power of attorney to IDBI Trusteeship on pledged shares; bankers contend this isn't legally possible

Jyothy recasts Ujala amid competition from Hindustan Unilever

Ujala accounts for 75% of the Rs 440-cr fabric blue market. While Reckitt Benckiser's Robin Blue has a share of 3.5%, HUL has a share of about


SBI signs MoU with Spanish bank

The MoU will give SBI direct access to Latin American market

Indian Bank to raise Rs 1,000 crore in Q3

Will merge two of its three subsidiaries with itself

SBI tightens lending norms, goes after NPAs

Steps up loan recovery to improve asset quality


New Trai whip on unwanted SMSes

Uniform termination charges, immediate probe and 2-year blacklist for unsolicited commercial use

Idea faces contempt case on Supreme Court's 3G pact order

Govt files case alleging telco breached directive not to get new customers in areas where it did not have 3G spectrum licence

RCom offers mobile connection to Aadhar holders

Customer won't need to submit photocopy of Aadhar documents; details will be verified via biometric device connection with Aadhar server


I can stand behind every pill: Ranbaxy CEO

Drug maker Ranbaxy Laboratories, which recently pleaded guilty of making fraudulent statements to the US Food and Drugs Administration (US FDA) ...

Ranbaxy | Crucial board meeting in Thakur's testimony goes missing

According to Ranbaxy's annual report, no meeting of the board of directors was held in September 2004

Ranbaxy cloud hasn't affected sales

Chemists, druggists and distributors said they hadn't seen any drop in prescription or sales of Ranbaxy drugs


Hindustan Motors to launch BS IV-compliant Ambassador

The crisis-ridden auto manufacturer has displayed the new model with BS IV diesel engine to Kolkata's taxi associations

Daimler rolls out Fuso truck for exports from Chennai unit

Firm plans to tap markets in Sri Lanka, Asia and Africa; Trucks won't be sold in India

Ssangyong receives 80 billion won from Mahindra

Money in lieu of the new shares offered to the Indian firm


People will fly if price is right: Neil Mills

Interview with CEO, SpiceJet

Lower revenue, exceptional items drag Jet books in Q4

Jet Airways (India) Ltd's domestic operations contributed to a bulk of its Rs 743 crore consolidated loss for the fourth quarter, whereas its ...

Jet loss widens 109%

Compensation from Boeing, sale & leaseback earnings prevent a steeper fall


Crompton Greaves Q4 net profit down 75% at Rs 25 cr

Company had posted net profit of Rs 100.32 crore for the January-March quarter of 2011-12 fiscal

RoadMin to take up GMR Infra project issue with Committee of Secy

According to sources, GMR too ready to start the project with some preconditions

BHEL FY13 net profit down 6%

Slowdown in order inflows, high input cost pull down growth


Siyaram Silk Mills expands retail biz, inks 27 franchise pacts

Firm aims at signing 90 deals by FY14-end, eyes 500 outlets in next four years

BCCI chief's kin comes under a cloud

India Cements stock cracks as betting accused names Chennai Super Kings CEO

Jai Corp looks to get out of Navi Mumbai SEZ

This is part of Jai Corp's efforts to raise funds as the investors of its real estate funds are increasingly demanding returns


Britannia Industries Q4 net up 49%

Revenue up by 12% to Rs 1,637 cr

Britannia Q4 net up 65.5% at Rs 88 cr

The company had reported net profit of Rs 53.03 crore during the January-March quarter of 2011-12 fiscal

Etienne Benet to take over as Nestle India Managing Director

Benet is currently the Chief Executive Officer of Nestle Central and West Africa Region


Zee Entertainment: Positives factored in

While subscription revenue growth is expected to remain strong, subdued ad revenue growth and rich valuations limit upsides

Ad revenues will rise on better price realisations: SL Narayan

Interview with CFO, Sun group

Zee Entertainment Jan-Mar profit rises 10.7%

For the financial year ended in March 2013, ZEEL posted a profit of Rs 718.15 compared to Rs 590.71 crore in 2011-12 fiscal


Nava Bharat seeks strategic investors for Odisha ops

The identification of the investors and evaluation of restructuring options are in progress, company says it is looking for investors with ...

CARE's global JV to be christened ARC Ratings

Will take over the businesses of Portugal-based rating agency

Voltas: Hopes of recovery dashed

Voltas is feeling the heat of economic and investment slowdown, both in the domestic and international markets


Opinion Rss icon

Image1

Ranbaxy a wake-up call for Indian pharma
Kiran Mazumdar Shaw

The industry must take strong collective action to protect the reputation it enjoys in global markets

Image1

The bluff must be called
Shyamal Majumdar

One is tempted to take Phaneesh Murthy's claims with a bagful of salt

Image1

Ranbaxy's dark chapter
Bhupesh Bhandari

Why have Indian authorities woken up to the Ranbaxy case only now? The matter had been simmering for several years

Brand World Rss icon

Image1

Tang gets ready to dissolve in the crowd

The powdered beverage brand tries out on-the-spot sampling in modern trade

Marquee brands set to jazz up fashion street

Entry of H&M, Gap and Uniqlo will change the game for casual-wear chains in India

Patented drugs find it tough to get branded

While heritage medicine brands continue to top best-selling lists, newer discoveries for complex ailments face the heat with high pricing

AnnouncementsRss icon

Quick Links

Financial X-Ray Rss icon

Market to see rush of fresh issuance

87 firms yet to comply with minimum public shareholding norms

SBI's asset quality hasn't hit a bottom

Higher provisioning and operational costs eat into profitability

L&T: Q4 numbers disappoint, but valuations don't

Company has historically traded at 28% premium to the Sensex but now valuations on a par with the benchmark

Colgate: P&G's toothpaste foray will raise competitive pressures

While analysts expect relatively lesser impact for Colgate, high stock valuations will cap further upsides